Neuroactive steroid modulation of GABAA receptors
1Department of Molecular and Medical Pharmacology, University of California, Los Angeles 90024-1735, USA.
Advances in Biochemical Psychopharmacology
|January 1, 1995
Summary
Neuroactive steroids modulate GABAA receptors, impacting the nervous system and offering potential treatments for neurological and psychiatric conditions like anxiety and epilepsy.
Area of Science:
- Neuroendocrinology
- Neuropharmacology
- Molecular Neuroscience
Background:
- Neuroactive steroids represent a significant class of endogenous compounds.
- Steroid hormone metabolites interact with the nervous system, particularly GABAA receptors.
- These interactions have profound physiological and pharmacological consequences.
Purpose of the Study:
- To explore the implications of GABAA receptor modulation by neuroactive steroids.
- To highlight the relevance of these interactions to human psychiatric and neurological disorders.
- To discuss the potential for developing new therapeutic agents targeting these pathways.
Main Methods:
- Review of existing literature on neuroactive steroids and GABAA receptor function.
- Analysis of the physiological and pharmacological effects of steroid modulation.
- Examination of clinical relevance in conditions such as anesthesia, anxiety, and epilepsy.
Main Results:
- Neuroactive steroids act as modulators of GABAA receptors, influencing neuronal excitability.
- These modulations are implicated in the mechanisms of general anesthesia and GABA tone.
- Evidence suggests roles in anti-anxiety and antiepileptic activities, with potential for new drug development.
Conclusions:
- GABAA receptors serve as critical non-genomic central nervous system targets for steroids.
- Neuroactive steroids have broad implications for understanding and treating neurological and psychiatric conditions.
- Further research into receptor subtypes and partial agonists may yield improved clinical outcomes.
More Related Videos
07:16Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
05:17BS3 Chemical Crosslinking Assay: Evaluating the Effect of Chronic Stress on Cell Surface GABAA Receptor Presentation in the Rodent Brain
Published on: May 26, 2023
Related Concept Videos
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
01:26Neurochemical Transmission: Sites of Drug Action
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
01:23Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
01:17Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...